Li‐Heng Pao
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems 4
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 9
- Cannabis and Cannabinoid Research 4
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals 8
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 9
- Cannabis and Cannabinoid Research 4
-
- Drug Transport and Resistance Mechanisms 11
-
- Liver Disease Diagnosis and Treatment 7
-
- Metabolomics and Mass Spectrometry Studies 6
-
- Hepatitis C virus research 6
Li‐Heng Pao
61 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 129
- Pharmaceutical Science 248
- Pharmacology 291
- Complementary and alternative medicine 152
- Analytical Chemistry 135
- Pharmacology 220
Countries citing papers authored by Li‐Heng Pao
This map shows the geographic impact of Li‐Heng Pao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Heng Pao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Heng Pao more than expected).
Fields of papers citing papers by Li‐Heng Pao
This network shows the impact of papers produced by Li‐Heng Pao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Heng Pao. The network helps show where Li‐Heng Pao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li‐Heng Pao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 4 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 9 | |
| 7 | 2017 | 32 | |
| 8 | 2016 | 33 | |
| 9 | 2015 | 15 | |
| 10 | 2015 | 16 | |
| 11 | 2015 | 6 | |
| 12 | 2014 | 149 | |
| 13 | 2012 | 27 | |
| 14 | 2012 | 3 | |
| 15 | 2011 | 3 | |
| 16 | 2004 | 16 | |
| 17 | 2003 | 9 | |
| 18 | 2000 | 20 | |
| 19 | 1999 | 25 | |
| 20 | 1999 | 363 |
About Li‐Heng Pao
Li‐Heng Pao is a scholar working on Pharmacology, Analytical Chemistry, Hepatology, Toxicology and Pharmaceutical Science, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (9 papers), Analytical Methods in Pharmaceuticals (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Metabolomics and Mass Spectrometry Studies (6 papers), Hepatitis C virus research (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Cannabis and Cannabinoid Research (4 papers). The work is most often cited by research in Pharmaceutical Science (248 citations), Pharmacology (291 citations), Complementary and alternative medicine (152 citations), Analytical Chemistry (135 citations) and Pharmacology (220 citations). Li‐Heng Pao has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include David Fleisher, Aziz Karim, Cheng Li, Jung Chao, Oliver Yoa‐Pu Hu, Yung‐Chi Cheng, Jiunn‐Wang Liao, Wen‐Huang Peng, Robert Verpoorte and Meng‐Shiou Lee. Their work appears in journals such as Journal of Food and Drug Analysis, Scientific Reports, Chromatographia, Journal of Chromatography B and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.